Dr. Saul Priceman is an Associate Professor in the Department of Medicine at USC, and the Founding Director of the KSOM/Norris Cancer Cellular Immunotherapy Research Center. Over the last 14 years, Dr. Priceman’s research has focused on T cell immunobiology and cancer immunotherapies. His laboratory develops CAR T cell therapies and combinatorial approaches for the treatment of solid cancers, bringing several therapies to phase 1 clinical testing. Dr. Priceman’s research has led to high-impact publications including in Nature Medicine, Science Translational Medicine, and Cell Metabolism, with numerous patents and technologies licensed for further clinical development. His research has been funded with grants from the NCI, DOD, CIRM, and Prostate Cancer Foundation. Dr. Priceman received his B.S. in microbiology at UCSB, his Ph.D. in molecular and medical pharmacology at UCLA, and his postdoctoral research at City of Hope.
